组学
特发性肺纤维化
表观遗传学
蛋白质组学
计算生物学
疾病
生物
代谢组学
基因组学
人类疾病
转录组
仿形(计算机编程)
生物信息学
肺
医学
计算机科学
基因组
病理
遗传学
基因
基因表达
内科学
DNA甲基化
操作系统
作者
Guoying Yu,Gabriel Ibarra,Naftali Kaminski
出处
期刊:Matrix Biology
[Elsevier BV]
日期:2018-08-01
卷期号:68-69: 422-434
被引量:37
标识
DOI:10.1016/j.matbio.2018.03.014
摘要
In recent decades there has been a significant shift in our understanding of idiopathic pulmonary fibrosis (IPF), a progressive and lethal disorder. While initially much of the mechanistic understanding was derived from hypotheses generated from animal models of disease, in recent decades new insights derived from humans with IPF have taken precedence. This is mainly because of the establishment of large collections of IPF lung tissues and patient cohorts, and the emergence of high throughput profiling technologies collectively termed 'omics' technologies based on their shared suffix. In this review we describe impacts of 'omics' analyses of human IPF samples on our understanding of the disease. In particular, we discuss the results of genomics and transcriptomics studies, as well as proteomics, epigenomics and metabolomics. We then describe how these findings can be integrated in a modified paradigm of human idiopathic pulmonary fibrosis, that introduces the 'hallmarks of aging' as a central theme in the IPF lung. This allows resolution of all the disparate cellular and molecular features in IPF, from the central role of epithelial cells, through the dramatic phenotypic alterations observed in fibroblasts and the numerous aberrations that inflammatory cells exhibit. We end with reiterating a call for renewed efforts to collect and analyze carefully characterized human tissues, in ways that would facilitate implementation of novel technologies for high resolution single cell omics profiling.
科研通智能强力驱动
Strongly Powered by AbleSci AI